Click for best price
Engineered Cell Therapy Market Size, Share 2024
| Market size in 2023 |
US$ 4352.5 million
|
Forecast Market size by 2030 |
US$ 10496.2 million
|
| Growth Rate |
CAGR of 13.4% |
Number of Pages |
112 Pages |
The global Engineered Cell Therapy market was valued at US$ 4352.5 million in 2023 and is projected to reach US$ 10496.2 million by 2030, at a CAGR of 13.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Synthetic Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Engineered Cell Therapy include Medtronic, Stryker, Zimmer Inc., Acelity, Allergan, Cook Medical, Baxter International, Organovo Holdings Inc and Integra LifeSciences, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Engineered cell therapy is designed to improve the ability of a patient's immune system to fight cancer by reintroducing improved immune cells. They are manufactured by collecting specific immune cells, called T cells, from the blood of the patient.
This report aims to provide a comprehensive presentation of the global market for Engineered Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Engineered Cell Therapy. This report contains market size and forecasts of Engineered Cell Therapy in global, including the following market information:
- Global Engineered Cell Therapy Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global top five companies in 2023 (%)
We surveyed the Engineered Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Engineered Cell Therapy Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Engineered Cell Therapy Market Segment Percentages, by Type, 2023 (%)
- Synthetic
- Biologically Derived
- Others
Global Engineered Cell Therapy Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Engineered Cell Therapy Market Segment Percentages, by Application, 2023 (%)
- Research Institutes
- Biotechnological Organizations
- Diagnostic Centres
Global Engineered Cell Therapy Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Engineered Cell Therapy Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Engineered Cell Therapy revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Engineered Cell Therapy revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Medtronic
- Stryker
- Zimmer Inc.
- Acelity
- Allergan
- Cook Medical
- Baxter International
- Organovo Holdings Inc
- Integra LifeSciences
- DePuy Synthes
- B. Braun Melsungen AG
- AbbVie
- Becton
- Dickinson and Company
- Organogenesis Inc.
- Athersys Inc.
- ReproCell Inc.
- RTI Surgical Inc.
- Tissue Regenix Group Plc
- RepliCel.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Engineered Cell Therapy, market overview.
Chapter 2: Global Engineered Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Engineered Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Engineered Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Engineered Cell Therapy Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 4352.5 million
|
| Forecast Market size by 2030 |
US$ 10496.2 million
|
| Growth Rate |
CAGR of 13.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
112 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Engineered Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Engineered Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Engineered Cell Therapy Overall Market Size
2.1 Global Engineered Cell Therapy Market Size: 2023 VS 2030
2.2 Global Engineered Cell Therapy Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Engineered Cell Therapy Players in Global Market
3.2 Top Global Engineered Cell Therapy Companies Ranked by Revenue
3.3 Global Engineered Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Engineered Cell Therapy Companies in Global Market, by Revenue in 2023
3.5 Global Companies Engineered Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Engineered Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Engineered Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Engineered Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Engineered Cell Therapy Market Size Markets, 2023 & 2030
4.1.2 Synthetic
4.1.3 Biologically Derived
4.1.4 Others
4.2 By Type - Global Engineered Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Engineered Cell Therapy Revenue, 2019-2024
4.2.2 By Type - Global Engineered Cell Therapy Revenue, 2025-2030
4.2.3 By Type - Global Engineered Cell Therapy Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Engineered Cell Therapy Market Size, 2023 & 2030
5.1.2 Research Institutes
5.1.3 Biotechnological Organizations
5.1.4 Diagnostic Centres
5.2 By Application - Global Engineered Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Engineered Cell Therapy Revenue, 2019-2024
5.2.2 By Application - Global Engineered Cell Therapy Revenue, 2025-2030
5.2.3 By Application - Global Engineered Cell Therapy Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Engineered Cell Therapy Market Size, 2023 & 2030
6.2 By Region - Global Engineered Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Engineered Cell Therapy Revenue, 2019-2024
6.2.2 By Region - Global Engineered Cell Therapy Revenue, 2025-2030
6.2.3 By Region - Global Engineered Cell Therapy Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Engineered Cell Therapy Revenue, 2019-2030
6.3.2 US Engineered Cell Therapy Market Size, 2019-2030
6.3.3 Canada Engineered Cell Therapy Market Size, 2019-2030
6.3.4 Mexico Engineered Cell Therapy Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Engineered Cell Therapy Revenue, 2019-2030
6.4.2 Germany Engineered Cell Therapy Market Size, 2019-2030
6.4.3 France Engineered Cell Therapy Market Size, 2019-2030
6.4.4 U.K. Engineered Cell Therapy Market Size, 2019-2030
6.4.5 Italy Engineered Cell Therapy Market Size, 2019-2030
6.4.6 Russia Engineered Cell Therapy Market Size, 2019-2030
6.4.7 Nordic Countries Engineered Cell Therapy Market Size, 2019-2030
6.4.8 Benelux Engineered Cell Therapy Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Engineered Cell Therapy Revenue, 2019-2030
6.5.2 China Engineered Cell Therapy Market Size, 2019-2030
6.5.3 Japan Engineered Cell Therapy Market Size, 2019-2030
6.5.4 South Korea Engineered Cell Therapy Market Size, 2019-2030
6.5.5 Southeast Asia Engineered Cell Therapy Market Size, 2019-2030
6.5.6 India Engineered Cell Therapy Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Engineered Cell Therapy Revenue, 2019-2030
6.6.2 Brazil Engineered Cell Therapy Market Size, 2019-2030
6.6.3 Argentina Engineered Cell Therapy Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Engineered Cell Therapy Revenue, 2019-2030
6.7.2 Turkey Engineered Cell Therapy Market Size, 2019-2030
6.7.3 Israel Engineered Cell Therapy Market Size, 2019-2030
6.7.4 Saudi Arabia Engineered Cell Therapy Market Size, 2019-2030
6.7.5 UAE Engineered Cell Therapy Market Size, 2019-2030
7 Engineered Cell Therapy Companies Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Engineered Cell Therapy Major Product Offerings
7.1.4 Medtronic Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.1.5 Medtronic Key News & Latest Developments
7.2 Stryker
7.2.1 Stryker Company Summary
7.2.2 Stryker Business Overview
7.2.3 Stryker Engineered Cell Therapy Major Product Offerings
7.2.4 Stryker Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.2.5 Stryker Key News & Latest Developments
7.3 Zimmer Inc.
7.3.1 Zimmer Inc. Company Summary
7.3.2 Zimmer Inc. Business Overview
7.3.3 Zimmer Inc. Engineered Cell Therapy Major Product Offerings
7.3.4 Zimmer Inc. Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.3.5 Zimmer Inc. Key News & Latest Developments
7.4 Acelity
7.4.1 Acelity Company Summary
7.4.2 Acelity Business Overview
7.4.3 Acelity Engineered Cell Therapy Major Product Offerings
7.4.4 Acelity Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.4.5 Acelity Key News & Latest Developments
7.5 Allergan
7.5.1 Allergan Company Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Engineered Cell Therapy Major Product Offerings
7.5.4 Allergan Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.5.5 Allergan Key News & Latest Developments
7.6 Cook Medical
7.6.1 Cook Medical Company Summary
7.6.2 Cook Medical Business Overview
7.6.3 Cook Medical Engineered Cell Therapy Major Product Offerings
7.6.4 Cook Medical Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.6.5 Cook Medical Key News & Latest Developments
7.7 Baxter International
7.7.1 Baxter International Company Summary
7.7.2 Baxter International Business Overview
7.7.3 Baxter International Engineered Cell Therapy Major Product Offerings
7.7.4 Baxter International Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.7.5 Baxter International Key News & Latest Developments
7.8 Organovo Holdings Inc
7.8.1 Organovo Holdings Inc Company Summary
7.8.2 Organovo Holdings Inc Business Overview
7.8.3 Organovo Holdings Inc Engineered Cell Therapy Major Product Offerings
7.8.4 Organovo Holdings Inc Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.8.5 Organovo Holdings Inc Key News & Latest Developments
7.9 Integra LifeSciences
7.9.1 Integra LifeSciences Company Summary
7.9.2 Integra LifeSciences Business Overview
7.9.3 Integra LifeSciences Engineered Cell Therapy Major Product Offerings
7.9.4 Integra LifeSciences Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.9.5 Integra LifeSciences Key News & Latest Developments
7.10 DePuy Synthes
7.10.1 DePuy Synthes Company Summary
7.10.2 DePuy Synthes Business Overview
7.10.3 DePuy Synthes Engineered Cell Therapy Major Product Offerings
7.10.4 DePuy Synthes Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.10.5 DePuy Synthes Key News & Latest Developments
7.11 B. Braun Melsungen AG
7.11.1 B. Braun Melsungen AG Company Summary
7.11.2 B. Braun Melsungen AG Business Overview
7.11.3 B. Braun Melsungen AG Engineered Cell Therapy Major Product Offerings
7.11.4 B. Braun Melsungen AG Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.11.5 B. Braun Melsungen AG Key News & Latest Developments
7.12 AbbVie
7.12.1 AbbVie Company Summary
7.12.2 AbbVie Business Overview
7.12.3 AbbVie Engineered Cell Therapy Major Product Offerings
7.12.4 AbbVie Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.12.5 AbbVie Key News & Latest Developments
7.13 Becton
7.13.1 Becton Company Summary
7.13.2 Becton Business Overview
7.13.3 Becton Engineered Cell Therapy Major Product Offerings
7.13.4 Becton Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.13.5 Becton Key News & Latest Developments
7.14 Dickinson and Company
7.14.1 Dickinson and Company Company Summary
7.14.2 Dickinson and Company Business Overview
7.14.3 Dickinson and Company Engineered Cell Therapy Major Product Offerings
7.14.4 Dickinson and Company Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.14.5 Dickinson and Company Key News & Latest Developments
7.15 Organogenesis Inc.
7.15.1 Organogenesis Inc. Company Summary
7.15.2 Organogenesis Inc. Business Overview
7.15.3 Organogenesis Inc. Engineered Cell Therapy Major Product Offerings
7.15.4 Organogenesis Inc. Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.15.5 Organogenesis Inc. Key News & Latest Developments
7.16 Athersys Inc.
7.16.1 Athersys Inc. Company Summary
7.16.2 Athersys Inc. Business Overview
7.16.3 Athersys Inc. Engineered Cell Therapy Major Product Offerings
7.16.4 Athersys Inc. Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.16.5 Athersys Inc. Key News & Latest Developments
7.17 ReproCell Inc.
7.17.1 ReproCell Inc. Company Summary
7.17.2 ReproCell Inc. Business Overview
7.17.3 ReproCell Inc. Engineered Cell Therapy Major Product Offerings
7.17.4 ReproCell Inc. Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.17.5 ReproCell Inc. Key News & Latest Developments
7.18 RTI Surgical Inc.
7.18.1 RTI Surgical Inc. Company Summary
7.18.2 RTI Surgical Inc. Business Overview
7.18.3 RTI Surgical Inc. Engineered Cell Therapy Major Product Offerings
7.18.4 RTI Surgical Inc. Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.18.5 RTI Surgical Inc. Key News & Latest Developments
7.19 Tissue Regenix Group Plc
7.19.1 Tissue Regenix Group Plc Company Summary
7.19.2 Tissue Regenix Group Plc Business Overview
7.19.3 Tissue Regenix Group Plc Engineered Cell Therapy Major Product Offerings
7.19.4 Tissue Regenix Group Plc Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.19.5 Tissue Regenix Group Plc Key News & Latest Developments
7.20 RepliCel.
7.20.1 RepliCel. Company Summary
7.20.2 RepliCel. Business Overview
7.20.3 RepliCel. Engineered Cell Therapy Major Product Offerings
7.20.4 RepliCel. Engineered Cell Therapy Revenue in Global Market (2019-2024)
7.20.5 RepliCel. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Engineered Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Engineered Cell Therapy Market Drivers in Global Market
Table 3. Engineered Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Engineered Cell Therapy in Global Market
Table 5. Top Engineered Cell Therapy Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Engineered Cell Therapy Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Engineered Cell Therapy Revenue Share by Companies, 2019-2024
Table 8. Global Companies Engineered Cell Therapy Product Type
Table 9. List of Global Tier 1 Engineered Cell Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Engineered Cell Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Engineered Cell Therapy Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Engineered Cell Therapy Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Engineered Cell Therapy Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Engineered Cell Therapy Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Engineered Cell Therapy Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Engineered Cell Therapy Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Engineered Cell Therapy Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Engineered Cell Therapy Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Engineered Cell Therapy Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Engineered Cell Therapy Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Engineered Cell Therapy Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Engineered Cell Therapy Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Engineered Cell Therapy Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Engineered Cell Therapy Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Engineered Cell Therapy Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Engineered Cell Therapy Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Engineered Cell Therapy Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Engineered Cell Therapy Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Engineered Cell Therapy Revenue, (US$, Mn), 2025-2030
Table 30. Medtronic Company Summary
Table 31. Medtronic Engineered Cell Therapy Product Offerings
Table 32. Medtronic Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 33. Medtronic Key News & Latest Developments
Table 34. Stryker Company Summary
Table 35. Stryker Engineered Cell Therapy Product Offerings
Table 36. Stryker Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 37. Stryker Key News & Latest Developments
Table 38. Zimmer Inc. Company Summary
Table 39. Zimmer Inc. Engineered Cell Therapy Product Offerings
Table 40. Zimmer Inc. Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 41. Zimmer Inc. Key News & Latest Developments
Table 42. Acelity Company Summary
Table 43. Acelity Engineered Cell Therapy Product Offerings
Table 44. Acelity Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 45. Acelity Key News & Latest Developments
Table 46. Allergan Company Summary
Table 47. Allergan Engineered Cell Therapy Product Offerings
Table 48. Allergan Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 49. Allergan Key News & Latest Developments
Table 50. Cook Medical Company Summary
Table 51. Cook Medical Engineered Cell Therapy Product Offerings
Table 52. Cook Medical Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 53. Cook Medical Key News & Latest Developments
Table 54. Baxter International Company Summary
Table 55. Baxter International Engineered Cell Therapy Product Offerings
Table 56. Baxter International Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 57. Baxter International Key News & Latest Developments
Table 58. Organovo Holdings Inc Company Summary
Table 59. Organovo Holdings Inc Engineered Cell Therapy Product Offerings
Table 60. Organovo Holdings Inc Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 61. Organovo Holdings Inc Key News & Latest Developments
Table 62. Integra LifeSciences Company Summary
Table 63. Integra LifeSciences Engineered Cell Therapy Product Offerings
Table 64. Integra LifeSciences Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 65. Integra LifeSciences Key News & Latest Developments
Table 66. DePuy Synthes Company Summary
Table 67. DePuy Synthes Engineered Cell Therapy Product Offerings
Table 68. DePuy Synthes Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 69. DePuy Synthes Key News & Latest Developments
Table 70. B. Braun Melsungen AG Company Summary
Table 71. B. Braun Melsungen AG Engineered Cell Therapy Product Offerings
Table 72. B. Braun Melsungen AG Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 73. B. Braun Melsungen AG Key News & Latest Developments
Table 74. AbbVie Company Summary
Table 75. AbbVie Engineered Cell Therapy Product Offerings
Table 76. AbbVie Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 77. AbbVie Key News & Latest Developments
Table 78. Becton Company Summary
Table 79. Becton Engineered Cell Therapy Product Offerings
Table 80. Becton Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 81. Becton Key News & Latest Developments
Table 82. Dickinson and Company Company Summary
Table 83. Dickinson and Company Engineered Cell Therapy Product Offerings
Table 84. Dickinson and Company Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 85. Dickinson and Company Key News & Latest Developments
Table 86. Organogenesis Inc. Company Summary
Table 87. Organogenesis Inc. Engineered Cell Therapy Product Offerings
Table 88. Organogenesis Inc. Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 89. Organogenesis Inc. Key News & Latest Developments
Table 90. Athersys Inc. Company Summary
Table 91. Athersys Inc. Engineered Cell Therapy Product Offerings
Table 92. Athersys Inc. Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 93. Athersys Inc. Key News & Latest Developments
Table 94. ReproCell Inc. Company Summary
Table 95. ReproCell Inc. Engineered Cell Therapy Product Offerings
Table 96. ReproCell Inc. Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 97. ReproCell Inc. Key News & Latest Developments
Table 98. RTI Surgical Inc. Company Summary
Table 99. RTI Surgical Inc. Engineered Cell Therapy Product Offerings
Table 100. RTI Surgical Inc. Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 101. RTI Surgical Inc. Key News & Latest Developments
Table 102. Tissue Regenix Group Plc Company Summary
Table 103. Tissue Regenix Group Plc Engineered Cell Therapy Product Offerings
Table 104. Tissue Regenix Group Plc Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 105. Tissue Regenix Group Plc Key News & Latest Developments
Table 106. RepliCel. Company Summary
Table 107. RepliCel. Engineered Cell Therapy Product Offerings
Table 108. RepliCel. Engineered Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 109. RepliCel. Key News & Latest Developments
List of Figures
Figure 1. Engineered Cell Therapy Segment by Type in 2023
Figure 2. Engineered Cell Therapy Segment by Application in 2023
Figure 3. Global Engineered Cell Therapy Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Engineered Cell Therapy Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Engineered Cell Therapy Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Engineered Cell Therapy Revenue in 2023
Figure 8. By Type - Global Engineered Cell Therapy Revenue Market Share, 2019-2030
Figure 9. By Application - Global Engineered Cell Therapy Revenue Market Share, 2019-2030
Figure 10. By Type - Global Engineered Cell Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Engineered Cell Therapy Revenue Market Share, 2019-2030
Figure 12. By Application - Global Engineered Cell Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Engineered Cell Therapy Revenue Market Share, 2019-2030
Figure 14. By Region - Global Engineered Cell Therapy Revenue Market Share, 2019-2030
Figure 15. By Country - North America Engineered Cell Therapy Revenue Market Share, 2019-2030
Figure 16. US Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Engineered Cell Therapy Revenue Market Share, 2019-2030
Figure 20. Germany Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 21. France Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Engineered Cell Therapy Revenue Market Share, 2019-2030
Figure 28. China Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 32. India Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Engineered Cell Therapy Revenue Market Share, 2019-2030
Figure 34. Brazil Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Engineered Cell Therapy Revenue Market Share, 2019-2030
Figure 37. Turkey Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Engineered Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 41. Medtronic Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Stryker Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Zimmer Inc. Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Acelity Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Allergan Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Cook Medical Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Baxter International Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Organovo Holdings Inc Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Integra LifeSciences Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. DePuy Synthes Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. B. Braun Melsungen AG Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. AbbVie Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Becton Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Dickinson and Company Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Organogenesis Inc. Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Athersys Inc. Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. ReproCell Inc. Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. RTI Surgical Inc. Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 59. Tissue Regenix Group Plc Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 60. RepliCel. Engineered Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
